SMTL ID : 3pdc.1

Crystal structure of hydrolase domain of human soluble epoxide hydrolase complexed with a benzoxazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x ZYI: N-(5-chloro-1,3-benzoxazol-2-yl)-2-cyclopentylacetamide(Non-covalent)

ZYI.1: 14 residues within 4Å: Chain A: F.63, D.131, W.132, M.135, T.156, Y.179, Q.180, L.204, M.215, L.224, Y.262, L.295, H.320, W.321 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.132, A:T.156, A:Y.179, A:L.204, A:L.295, A:W.321 Hydrogen bonds: A:Y.262 pi-Stacking: A:F.63 ZYI.2: 14 residues within 4Å: Chain B: F.63, D.131, W.132, T.156, Y.179, Q.180, F.183, L.204, M.215, L.224, Y.262, L.295, H.320, W.321 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:T.156, B:Y.179, B:L.204, B:W.321 Hydrogen bonds: B:Y.179 pi-Stacking: B:F.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xing, L. et al., Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening. J.Med.Chem. (2011)

Release Date

2011-04-06

Peptides

Epoxide hydrolase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Epoxide hydrolase 2